CYP 2.63% 19.5¢ cynata therapeutics limited

Ann: Investor Presentation, page-257

  1. 4,079 Posts.
    lightbulb Created with Sketch. 300
    "Cynata's technology came about after bone-marrow derived technologies, so naturally they are not as far down the road, relatively speaking. However, it doesn't mean that Cynata will not continue to advance the technology in a clinical setting and increase the value in the short and long term."

    So you acknowledge
    1. CYP is well behind
    2. Cynata are in a petri dish stage
    3. Cynata have no contemplation or considerations for a manufacturing facility
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
19.5¢
Change
0.005(2.63%)
Mkt cap ! $34.32M
Open High Low Value Volume
19.5¢ 19.5¢ 19.5¢ $180 921

Buyers (Bids)

No. Vol. Price($)
2 75000 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
19.5¢ 38852 1
View Market Depth
Last trade - 10.02am 13/09/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.